Implementing Cancer Medicines on the WHO Model Lists of Essential Medicines Into National Systems

This Viewpoint discusses national systems implementation of cancer medicines included in the WHO Model Lists of Essential Medicines.

Corresponding Author: Kristina Jenei, RN, MSc, London School of Economics and Political Science, Houghton St, London, United Kingdom, WC2A 2AE (k.jenei@lse.ac.uk).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.